159 related articles for article (PubMed ID: 15863212)
1. Acute myeloid leukemia cell lines MOLM-17 and MOLM-18 derived from patient with advanced myelodysplastic syndromes.
Matsuo Y; Drexler HG; Harashima A; Okochi A; Kojima K; Asakura S; Tanimoto M; Orita K
Leuk Res; 2005 Jun; 29(6):701-10. PubMed ID: 15863212
[TBL] [Abstract][Full Text] [Related]
2. New cytokine-dependent acute myeloid leukemia cell line MUTZ-11 with disomic chromosome rearrangement t(16;17).
Hu ZB; Quentmeier H; Meyer C; Kaufmann M; MacLeod RA; Drexler HG
Leuk Res; 2004 May; 28(5):509-15. PubMed ID: 15068904
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of novel myeloid precursor cell line, PC-MDS, established from a bone marrow of the patient with therapy-related myelodysplastic syndrome.
Bogdanović G; Jurisić V; Kraguljac N; Mrdjanović J; Jakimov D; Krtolica K; Krajnović M; Magić Z; Stojiljković B; Andrijević L; Srdić T; Baltić M; Popović S
Leuk Res; 2007 Aug; 31(8):1097-1105. PubMed ID: 17350682
[TBL] [Abstract][Full Text] [Related]
4. Megakaryoblastic leukemia cell line MOLM-16 derived from minimally differentiated acute leukemia with myeloid/NK precursor phenotype.
Matsuo Y; Drexler HG; Kaneda K; Kojima K; Ohtsuki Y; Hara M; Yasukawa M; Tanimoto M; Orita K
Leuk Res; 2003 Feb; 27(2):165-71. PubMed ID: 12526922
[TBL] [Abstract][Full Text] [Related]
5. Late appearance of Philadelphia chromosome with the p190 BCR/ABL chimeric transcript in acute myelogenous leukemia progressing from myelodysplastic syndrome.
Kakihana K; Mizuchi D; Yamaguchi M; Sakashita C; Fukuda T; Yamamoto K; Miki T; Murakami N; Miura O
Rinsho Ketsueki; 2003 Apr; 44(4):242-8. PubMed ID: 12784657
[TBL] [Abstract][Full Text] [Related]
6. del11(p11-13) with overexpression of Wilms' tumor gene during leukemic transformation of myelodysplastic syndrome.
Suzuki S; Hashino S; Yoshida S; Chiba K; Izumiyama K; Kurosawa M; Musashi M; Asaka M
Ann Hematol; 2002 Oct; 81(10):605-8. PubMed ID: 12424545
[TBL] [Abstract][Full Text] [Related]
7. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
Ogasawara T; Yasuyama M; Kawauchi K
Am J Hematol; 2005 Jun; 79(2):136-41. PubMed ID: 15929101
[TBL] [Abstract][Full Text] [Related]
8. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
[TBL] [Abstract][Full Text] [Related]
9. Double minute chromosomes contain amplified c-myc oncogene sequences in acute myeloid leukemia.
Mohamed AN; Mahalak S; Goldfarb SB; Palutke M
Hematopathol Mol Hematol; 1996; 10(4):193-9. PubMed ID: 9042662
[TBL] [Abstract][Full Text] [Related]
10. [Acute myelogenous leukemia transformed from myelodysplastic syndrome with tetraploid chromosome constitution].
Furuya H; Tsuchiyama S; Sato T; Ishibashi R; Notsu K; Takagi C; Yamamoto H; Kato Y
Rinsho Ketsueki; 1992 Apr; 33(4):494-9. PubMed ID: 1602614
[TBL] [Abstract][Full Text] [Related]
11. Chromosome studies of enriched blast cell fractions in myelodysplastic syndromes terminating in acute myeloid leukemia.
Piva N; Cuneo A; Carli MG; Cariani D; Fagioli F; Castoldi G
Haematologica; 1990; 75(6):522-6. PubMed ID: 2098292
[TBL] [Abstract][Full Text] [Related]
12. Immunophenotypic analysis of myelodysplastic syndromes.
Del Cañizo MC; Fernández ME; López A; Vidriales B; Villarón E; Arroyo JL; Ortuño F; Orfao A; San Miguel JF
Haematologica; 2003 Apr; 88(4):402-7. PubMed ID: 12681967
[TBL] [Abstract][Full Text] [Related]
13. Many are called MDS cell lines: one is chosen.
Drexler HG; Dirks WG; Macleod RA
Leuk Res; 2009 Aug; 33(8):1011-6. PubMed ID: 19344951
[TBL] [Abstract][Full Text] [Related]
14. Malignant hematopoietic cell lines: in vitro models for the study of erythroleukemia.
Drexler HG; Matsuo Y; MacLeod RA
Leuk Res; 2004 Dec; 28(12):1243-51. PubMed ID: 15475063
[TBL] [Abstract][Full Text] [Related]
15. Accelerated cellular senescence in myelodysplastic syndrome.
Wang YY; Cen JN; He J; Shen HJ; Liu DD; Yao L; Qi XF; Chen ZX
Exp Hematol; 2009 Nov; 37(11):1310-7. PubMed ID: 19748549
[TBL] [Abstract][Full Text] [Related]
16. New human myelodysplastic cell line, TER-3: G-CSF specific downregulation of Ca2+/calmodulin-dependent protein kinase IV.
Mishima Y; Terui Y; Mishima Y; Katsuyama M; Mori M; Tomizuka H; Takizawa T; Miyazato A; Ueda M; Yamada M; Hayasawa H; Mizunuma N; Ishizaka Y; Ikeda K; Kato T; Ozawa K; Hatake K
J Cell Physiol; 2002 May; 191(2):183-90. PubMed ID: 12064461
[TBL] [Abstract][Full Text] [Related]
17. New acute myeloid leukemia-derived cell line: MUTZ-8 with 5q-.
Hu ZB; MacLeod RA; Meyer C; Quentmeier H; Drexler HG
Leukemia; 2002 Aug; 16(8):1556-61. PubMed ID: 12145698
[TBL] [Abstract][Full Text] [Related]
18. Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in malignant hematological disorders: correlation with apoptosis.
Qi H; Xiao L; Lingyun W; Ying T; Yi-Zhi L; Shao-Xu Y; Quan P
Ann Hematol; 2006 Feb; 85(2):95-101. PubMed ID: 16328478
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
[TBL] [Abstract][Full Text] [Related]
20. Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines.
Estrov Z; Kurzrock R; Pocsik E; Pathak S; Kantarjian HM; Zipf TF; Harris D; Talpaz M; Aggarwal BB
J Exp Med; 1993 Mar; 177(3):763-74. PubMed ID: 8382256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
